McNeil Consumer Healthcare

Johnson & Johnson Recalls More Children's Medicines

Just days after Johnson & Johnson's Children's Tylenol started returning to store shelves, the health care giant has recalled about four million packages of Children's Benadryl allergy tablets and some 800,000 bottles of Junior Strength Motrin, citing manufacturing problems.

J&J Earnings Hurt by Children's Medicine Recalls

Tylenol and Band-Aid maker Johnson & Johnson announced on Tuesday that its sales declined 0.7% to $15 billion in the third quarter, compared to the same quarter last year, as domestic sales were "significantly impacted" by recent successive recalls. Domestic sales declined 2.5%.

J&J Apologizes for Kids Medicine Issues, Phantom Recalls

In testimony before Congress Thursday, Johnson & Johnson's CEO apologized for the problems that have beset his company, including the quality issues with its children's medicines and the "phantom recall" of a batch of Motrin. He also said new batches of its children's medicines should start shipping next week.

What Buffett's Buying: A Stake in Fiserv, More J&J

Each quarter, investors and the media await the latest filing from Warren Buffett's Bekshire Hathaway to see what changes the Oracle of Omaha made to his portfolio. But why is he buying a piece of payment processor Fiserv and raising his stake in Johnson & Johnson?

Johnson & Johnson Earnings Up, but Recalls Cut Guidance

Johnson & Johnson's earnings for the second quarter of 2010 rose 5.4% to $3.4 billion, or $1.23 per share, from $3.2 billion or $1.15 per share, the company announced Tuesday morning. Adjusted earnings, which exclude litigation costs, were $1.21 per share.

McNeil Expands Recall of Tylenol, Motrin, Benadryl

Johnson & Johnson subsidiary McNeil recalled another batch of over-the-counter medicines Thursday. The specific lots of Tylenol, Motrin and Benadryl products may have been contaminated with trace amounts of a chemical that gives them a musty or moldy odor.

J&J Recall Hearing: Contradictions and Cover-Ups

At Congress' hearings on Johnson & Johnson's huge recall of Children's Tylenol, among other drugs, the company's statements were contradicted by the Food and Drug Administration, and details of J&J's Motrin "phantom recall" were revealed.

J&J's Motrin Recall Cover-Up Revealed

Ahead of a Congressional hearing over Johnson & Johnson's big drug recall, internal documents were revealed that showed the drugmaker trying to conduct a stealth recall of Motrin in 2008. That's just one of the series of problems discovered at J&J.

Johnson & Johnson Fights Charges of Recalls and Kickbacks

Johnson & Johnson shares are rebounding as the drugmaker tries to recover from a rough week, when the Justice Department charged it with paying kickbacks to a pharmacy company to boost sales of its drugs to nursing-home patients, and the Food and Drug Administration accused it of being too slow with its product recall during a Tylenol scare.